Bedding manufacturer and retailer Sleep Number (NASDAQ:SNBR) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 7.8% year on year to $347.4 million. Its non-GAAP loss of $1.95 per ...
Bicara Therapeutics (NASDAQ:BCAX) is developing tumor-targeting bifunctional antibodies, with its lead candidate ficerasfusp alfa designed to address both EGFR and TGF-beta biology in cancer, company ...
Get all latest & breaking news on Closing High. Watch videos, top stories and articles on Closing High at moneycontrol.com.